Association of 2238TC polymorphism of the atrial natriuretic peptide gene with coronary artery disease in afro-caribbeans with type 2 diabetes

American Journal of Hypertension

Volumn 25, Issue 5, 2012, Pages 524-527

  Larifla, Laurent ^a   Maimaitiming, Suriya ^b   Velayoudom Cephise, Fritz Line ^a   Ferdinand, Severine ^c   Blanchet Deverly, Anne ^a   Benabdallah, Sonia ^a   Donnet, Jean Paul ^a   Atallah, André ^d   Roussel, Ronan ^b,e   Foucan, Lydia ^a,c  

^a University of the French West Indies   (France)

^b INSERM   (France)

^c Research Group Clinical Epidemiology   (France)

^d La Basse Terre Hospital   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

ANP gene polymorphism; blood pressure; coronary artery disease; genetics; hypertension; natriuretic peptides; type 2 diabetes

Indexed keywords

ATRIAL NATRIURETIC FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AFRICAN AMERICAN; AGE; AGED; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GENDER; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARIBBEAN ISLANDS; COMORBIDITY; CROSS-SECTIONAL STUDY; ETHNOLOGY; GENETICS; MIDDLE AGED; NEGRO; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR DISEASES; COMORBIDITY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; WEST INDIES;

EID: 84859900299     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.233     Document Type: Article

References (14)

1. Cody RJ, Atlas SA, Laragh JH. Physiologic and pharmacologic studies of atrial natriuretic factor: a natriuretic and vasoactive peptide. J Clin Pharmacol 1987; 27:927-936.
2. Casco VH, Veinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem 2002; 50:799-809. (Pubitemid 34721448)
3. Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol 2005; 25:2032-2042. (Pubitemid 41416298)
4. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008; 21:733-741. (Pubitemid 351913612)
5. Vassalle C, Andreassi MG. Genetic polymorphisms of the natriuretic peptide system in the pathogenesis of cardiovascular disease: what lies on the horizon? Clin Chem 2009; 55:878-887.
6. Gruchala M, Ciecwierz D, Wasag B, Targonski R, Dubaniewicz W, Nowak A, Sobiczewski W, Ochman K, Romanowski P, Limon J, Rynkiewicz A. Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 2003; 145:125-131. (Pubitemid 36034507)
7. Roussel R, Trégouët DA, Hadjadj S, Jeunemaître X, Marre M. Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. Diabetes 2004; 53:1394-1398. (Pubitemid 38569028)
8. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, Tarasi D, Gigante B, Pirisi A, Brunetti E, Volpe M. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004; 35:814-818. (Pubitemid 38419783)
9. Nannipieri M, Penno G, Pucci L, Colhoun H, Motti C, Bertacca A, Rizzo L, De Giorgio L, Zerbini G, Mangili R, Navalesi R. Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 1999; 10:1530-1541. (Pubitemid 29297528)
10. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, Yazaki Y. Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin Sci 2000; 98:251-258. (Pubitemid 30145230)
11. Vassalle C, Andreassi MG, Prontera C, Fontana M, Zyw L, Passino C, Emdin M et al. Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure. Clin Chem 2007; 53:1886-1890. (Pubitemid 350036031)
12. Kiemer AK, Fürst R, Vollmar AM. Vasoprotective actions of the atrial natriuretic peptide. Curr Med Chem Cardiovasc Hematol Agents 2005; 3:11-21. (Pubitemid 40057727)
13. Rautureau Y, Baxter GF. Acute actions of natriuretic peptides in coronary vasculature and ischaemic myocardium. Curr Pharm Des 2004; 10:2477-2482. (Pubitemid 38997428)
14. Rutledge DR, Sun Y, Ross EA. Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 1995; 13:953-955.